P037: Remodelling events preceding clinical onset of intestinal inflammation reveal the predictive power of the extracellular matrix ECCO '16 Amsterdam
2016
P038: Revised roles of matrix metalloproteinase/MMP-9 in inflammatory bowel diseases: from target to biomarkerECCO '16 Amsterdam
2016
P039: Expression of the liver homing receptor CXCR3+ on colonic CD8+ T lymphocytes in patients with primary sclerosing cholangitis provides a possible link between colonic and biliary duct inflammation.ECCO '16 Amsterdam
2016
P040: Sonic hedgehog inhibitor prevented colitis-associated cancer via concerted mechanisms of IL-6/gp130 inhibition, 15-prostaglandin dehydrogenase induction, Bcl-2 abrogation, and tumour sphere inhibitionECCO '16 Amsterdam
2016
P041: Automated image analysis as a diagnostic tool in discriminating between subgroups of microscopic colitisECCO '16 Amsterdam
2016
P042: Circulating IL9 in inflammatory bowel disease: possible marker of mucosal non-healingECCO '16 Amsterdam
2016
P043: Inhibition of miR-142-5P ameliorates disease in mouse models of experimental colitisECCO '16 Amsterdam
2016
P044: Roles of IL-33 on murine colitis and M2 macrophage differentiation in inflammatory bowel diseasesECCO '16 Amsterdam
2016
P045: The relationship between thiol/disulphide and inflammatory bowel diseaseECCO '16 Amsterdam
2016
P046: Therapeutic effects of mouse bone marrow–derived single clonal mesenchymal stem cells in a mouse model of inflammatory bowel diseaseECCO '16 Amsterdam
2016
P047: Enterocytes and dendritic cells both contribute to the intestinal inflammation in paediatric inflammatory bowel diseasesECCO '16 Amsterdam
2016
P048: Cigarette smoke impairs intestinal epithelial cell polarity development and morphogenesisECCO '16 Amsterdam
2016
P049: Prevalence and factors associated with vitamin D deficiency in patients with inflammatory bowel disease on biologic therapiesECCO '16 Amsterdam
2016
P050: Proinflammatory action of 5-HT in colon epithelial cell response to gut bacteria through NOX2 inductionECCO '16 Amsterdam
2016
P051: Chemokines CXCL17, CCL20, and the receptor CXCR5 are overexpressed in the colonic mucosa from patients with active ulcerative colitis: CXCL17 is a potential marker of histological remissionECCO '16 Amsterdam
2016
P052: Intestinal total bacteria concentration and translocation of bacteria in inflammatory bowel diseaseECCO '16 Amsterdam
2016
P053: Histological and immunohistochemical indicators of progression towards malignancy in ulcerative colitisECCO '16 Amsterdam
2016
P054: Soluble GPVI is raised in patients with inflammatory bowel disease and anaemiaECCO '16 Amsterdam
2016